Heron Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 34.7M | 40.6M | 38.2M | 37.2M | 38.9M | 40.8M | 32.8M | 36.0M |
| Cost of Goods Sold | 10.6M | 7.6M | 15.4M | 9.9M | 8.5M | 10.2M | 9.5M | 10.5M |
| Gross Profit | 24.1M | 32.9M | 22.8M | 27.3M | 30.4M | 30.6M | 23.4M | 25.5M |
| R&D Expenses | 2.4M | 3.7M | 3.5M | 2.9M | 2.3M | 3.2M | 4.5M | 4.4M |
| Operating Expenses | 28.8M | 32.9M | 26.9M | 29.0M | 27.3M | 26.4M | 27.8M | 32.0M |
| Operating Income | -4.8M | 38K | -4.1M | -1.6M | 3.2M | 4.2M | -4.5M | -6.4M |
| Other Income / Gains | -3.3M | -3.0M | -13.4M | -744K | -519K | -510K | -390K | -2.8M |
| Net Income | -8.1M | -3.0M | -17.5M | -2.4M | 2.6M | 3.7M | -4.8M | -9.2M |
| EPS (Diluted) | -0.04 | -0.017 | -0.10 | -0.02 | 0.017 | 0.024 | -0.032 | -0.061 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.694 | 0.812 | 0.597 | 0.735 | 0.783 | 0.749 | 0.712 | 0.708 |
| General And Administrative Expenses | 12.1M | 13.5M | 14.0M | 14.5M | 12.7M | 12.1M | 12.4M | 13.9M |
| Selling And Marketing Expenses | 14.3M | 12.2M | 12.9M | 11.6M | 12.3M | 11.1M | 11.0M | 13.6M |
| Selling General And Administrative Expenses | 26.5M | 25.7M | 26.9M | 26.0M | 25.0M | 23.2M | 23.3M | 27.5M |
| Other Expenses | 0 | 3.5M | -3.5M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 39.5M | 40.5M | 42.3M | 38.8M | 35.7M | 36.6M | 37.3M | 42.5M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 1.0M | 2.9M | 0 | 500K | 4.4M | 500K | 400K |
| Depreciation And Amortization | 529K | 1.2M | 615K | 611K | 551K | 581K | 581K | 641K |
| Ebitda | -7.6M | -792K | -14.0M | -1.8M | 3.7M | 8.7M | -3.8M | -8.2M |
| Ebitdaratio | -0.218 | -0.02 | -0.366 | -0.048 | 0.095 | 0.214 | -0.115 | -0.227 |
| Operating Income Ratio | -0.137 | 0.001 | -0.107 | -0.044 | 0.081 | 0.102 | -0.136 | -0.179 |
| Income Before Tax | -8.1M | -3.0M | -17.5M | -2.4M | 2.6M | 3.7M | -4.8M | -9.2M |
| Income Before Tax Ratio | -0.234 | -0.073 | -0.458 | -0.064 | 0.068 | 0.09 | -0.148 | -0.256 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.234 | -0.073 | -0.458 | -0.064 | 0.068 | 0.09 | -0.148 | -0.256 |
| Epsdiluted | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 | 0.024 | -0.032 | -0.061 |
| Weighted Average Shs Out | 189.6M | 166.7M | 170.3M | 154.0M | 153.5M | 153.2M | 152.8M | 152.3M |
| Weighted Average Shs Out Dil | 189.6M | 166.7M | 170.3M | 154.0M | 153.5M | 153.2M | 152.8M | 152.3M |